The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6592-6598

  Iwakura, Yoichiro ^a   Itagaki, Keiko ^a   Ishitsuka, Chiho ^a   Yamasaki, Yoshiki ^a,b   Matsuzawa, Akio ^a   Yonehara, Shin ^c   Karasawa, Shigeru ^d   Ueda, Susumu ^d   Saijo, Shinobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Life Science Research Laboratory   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; H2 ANTIGEN;

ANIMAL MODEL; APOPTOSIS; ARTHROPATHY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENE LOCUS; HAPLOTYPE; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS GENE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CLONAL DELETION; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; GENES, ENV; GENES, PX; H-2 ANTIGENS; HAPLOTYPES; HUMAN T-LYMPHOTROPIC VIRUS 1; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; RHEUMATOID FACTOR; SPECIES SPECIFICITY;

EID: 0032534743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Firestein, G. S., and N. J. Zvaifler. 1992. Rheumatoid arthritis: a disease of disordered immunity. In Inflammation: Basic Principles and Clinical Correlates, 2nd Ed. J. L. Gallen, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York.
2. Gregersen, P. K. 1989. HLA class II polymorphysm: implications for genetic susceptibility to autoimmune disease. Lab. Invest. 61:5.
3. Vaughan, J. H. 1993. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum. 36:1.
4. Andriopoulos, N. A., J. Mestecky, E. J. Miller, and E. L. Bradley. 1976. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 19:613.
5. Clague, R. B., M. J. Shaw, and P. J. Holt. 1980. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann. Rheum. Dis. 39:201.
6. Tarkowski, A., L. Klareskog, H. Carlsten, P. Herberts, and W. Koopman. 1989. Secretion of antibodies to type I and type II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 32:1087.
7. van Eden, W., J. E. R. Thole, R. v. d. Zee, A. Noordzij, J. D. A. v. Embden, E. J. Hensen, and I. R. Cohen. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331:171.
8. Arend, W. P., and J.-M. Dayer. 1990. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33:305.
9. Bucala, R., C. Ritchlin, R. Winchester, and A. Cerami. 1991. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173:569.
10. Yamagata, N., K. Kobayashi, T. Kasama, T. Fukushima, M. Tabata, I. Yoneya, Y. Shikama, S. Kaga, M. Hashimoto, K. Yoshida, et al. 1988. Multiple cytokine activities and loss of interleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J. Rheumatol. 15:1623.
11. Sugamura, K., and Y. Hinuma. 1993. Human retroviruses: HTLV-I and HTLV-II. In The Retroviridae, Vol. 2. A. Levy, ed. Plenum Press, New York, p. 399.
12. Yoshida, M. 1993. HTLV-I tax: regulation of gene expression and disease. Trends Microbiol. 1:131.
13. Maruyama, M., H. Shibuya, H. Harada, M. Hatakeyama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343.
14. Siekevitz, M., M. B. Feinberg, N. Holbrook, F. Wong-Staal, and W. C. Greene. 1987. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc. Natl. Acad. Sci. USA 84:5389.
15. Kim, S.-J., J. H. Kehrl, J. Burton, C. L. Tendler, K.-T. Jeang, D. Danielpour, C. Thevenin, K. Y. Kim, M. B. Sporn, and A. B. Roberts. 1990. Transactivation of the transforming growth factor 1 (TGF-β1) gene by human T lymphotropic virus type I Tax: a potential mechanism for the increased production of TGF-β1 in adult T cell leukemia. J. Exp. Med. 172:121.
16. Miyatake, S., M. Seiki, M. Yoshida, and K. Aral. 1988. T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element. Mol. Cell. Biol. 8:5581.
17. Inoue, J., M. Seiki, T. Taniguchi, S. Tsuru, and M. Yoshida. 1986. Induction of interleukin 2 receptor gene expression by p40x-encoded by human T-cell leukemia virus type I. EMBO J. 5:2883.
18. Green, J. E., C. G. Begley, D. K. Wagner, T. A. Waldmann, and G. Jay. 1989. Transactivation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol. Cell. Biol. 9:4731.
19. Fujii, M., P. Sassone-Corsi, and I. M. Verma. 1988. c-fos promoter trans-activation by the tax 1 protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 85:8526.
20. Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, and M. Seiki. 1991. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene 6:1023.
21. Iwakura, Y., M. Tosu, E. Yoshida, M. Takiguchi, K. Sato, I. Kitajima, K. Nishioka, K. Yamamoto, T. Takeda, M. Hatanaka, H. Yamamoto, and T. Sekiguchi. 1991. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026.
22. Yamamoto, H., T. Sekiguchi, K. Itagaki, S. Saijo, and Y. Iwakura. 1993. Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthritis Rheum. 36:1612.
23. Iwakura, Y., S. Saijo, Y. Kioka, J. Yamada, K. Itagaki, M. Tosu, M. Asano, Y. Kanai, and K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588.
24. Endo, T., Y. Iwakura, and A. Kobata. 1993. Structural changes in the N-linked sugar chains of serum immunoglobulin G of HTLV-I transgenic mice. Biochem. Biophys. Res. Commun. 192:1004.
25. Iwakura, Y., M. Tosu, E. Yoshida, S. Saijo, J. Nakayama-Yamada, K. Itagaki, M. Asano, H. Siomi, M. Hatanaka, T. Takeda, T. Nunoya, S. Ueda, and H. Shibuta. 1994. Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type-I tax gene. Virus Genes 9:161.
26. Nishioka, K., T. Sumida, and T. Hasunuma. 1996. Human T lymphotropic virus type I in arthropathy and autoimmune disorders. Arthritis Rheum. 39:1410.
27. Kishi, S., S. Saijo, M. Arai, S. Karasawa, S. Ueda, M. Kannagi, Y. Iwakura. M. Fujii, and S. Yonehara. 1997. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) Transgenic mice with autoimmune arthropathy. J. Exp. Med. 186:57.
28. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen apoptosis. Nature 356:314.
29. Shreffler, D. C. 1980. H-2 Congenic Lines Carrying Standerd Haplotype: Mouse. Federation of American Societies for Experimental Biology, Bethesda, MD.
30. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
31. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Permutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821.
32. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen. Proc. Natl. Acad. Sci. USA 90:1756.
33. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
34. Lomedico, P. T., U. Gubler, C. P. Hellmann, M. Dukovich, J. G. Giri, Y.-C. E. Pan, K. Collier, R. Semionow, A. O. Chua, and S. B. Mizel. 1986. Cloning and expression of murine interleukin-1 cDNA in Esherichia coli. Nature 312:458.
35. Weiss, E., L. Golden, R. Zakut, A. Mellor, K. Fahmer, S. Kvist, and R. A. Flavell. 1987. The DNA sequence of the H-2Kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens. EMBO J. 2:453.
36. Widera, G., L. C. Burkly, C. A. Pinkert, E. C. Bottger, C. Cowing, R. D. Palmiter, R. L. Brinster, and R. A. Flavell. 1987. Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell 51:175.
37. Mathis, D. J., B. Cheristophe, V. E. Williams II, M. Kater, and H. O. Mcdevitt. 1983. Several mechanisms can account for defective Ea gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA 80:273.
38. Nossal, G. J. 1994. Negative selection of lymphocytes. Cell 76:229.
39. Kotani, M., Y.-I. Tagawa, and Y. Iwakura. 1998. Involvement of autoimmunity against type II collagen in development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene. Eur. J. Immunol. 28:1.
40. Wooley, P. H., H. S. Luthra, J, M. Stuart, and C. S. David. 1981. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J. Exp. Med. 154:688.
41. Zanelli, E., C. J. Krco, J. M. Baisch, S. Cheng, and C. S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93:1814.
42. Nabozny, G. H., M. J. Bull, J. Hanson, M. M. Griffiths, H. S. Luthra, and C. S. David. 1994. Collagen-induced arthritis in T cell receptor Vb congenic B10.Q mice. J. Exp. Med. 180:517.
43. Gonzalez-Gay, M. A., G. H. Nabozny, M. J. Bull, E. Zanelli, J. Douhan, M. M. Griffiths, L. H. Glimcher, H. S. Luthra, and C. S. David. 1994. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J. Exp. Med. 180:1559.
44. Wordsworth, B. P., J. S. S. Lanchbury, L. I. Sakkas, K. I. Welsh, G. S. Panayi, and J. I. Bell. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major suspectibility licus within the HLA. Proc. Natl. Acad. Sci. USA 86:10049.
45. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
46. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94:3914.
47. Guierres-ramos, J. C., I. M. Alboran, and C. Martinez-A. 1992. In vivo administration of interleukin-2 turns on anergic self-reactive T cell and leads to autoimmune disease. Eur. J. Immunol. 22:2867.
48. Nakata, Y., K. Matsuda, A. Uzawa, M. Nomura, M. Akashi, and G. Suzuki. 1995. Administration of recombinant human IL-1 by staphylococcus enterotoxin B prevents tolerance induction in vivo. J. Immunol. 155:4231.